CPT code 95132 covers in-office administration of stinging insect venom extracts for three insect species to treat or prevent allergic reactions in patients with venom hypersensitivity. This code is used by allergy and immunology providers to bill for venom immunotherapy injections given in a clinic setting, a clinically important intervention that reduces risk of systemic allergic reactions and emergency care. Nationally, accurate use of this code affects access to effective preventive care for patients with insect sting allergy and influences payer coverage decisions and clinical documentation practices.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for venom immunotherapy, expected site-of-service implications, common billing considerations, and payer coverage landscape. The publication provides benchmarks for utilization and reimbursement where available, highlights relevant policy updates that affect coding and coverage, and explains documentation elements that support medical necessity determinations.

Intended for clinical coders, allergy specialists, billing professionals, and policy analysts, the content outlines practical coding guidance, common modifiers and billing scenarios, and connections to related services and diagnosis documentation. Data not supplied in the input (such as payer-specific fee schedules, ICD-10 pairings, and associated taxonomies) are noted as unavailable where applicable.